National Health Investors, Inc. (NYSE:NHI) Receives $75.33 Consensus PT from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $75.33.

A number of analysts recently commented on the stock. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Bank of America started coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective on the stock. Finally, Truist Financial lowered their target price on National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd.

National Health Investors Stock Performance

Shares of NHI stock opened at $67.53 on Tuesday. The stock has a market cap of $3.07 billion, a PE ratio of 23.21, a price-to-earnings-growth ratio of 4.86 and a beta of 1.06. The stock has a 50-day moving average of $73.82 and a 200-day moving average of $75.76. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. National Health Investors has a one year low of $51.59 and a one year high of $86.13.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The firm had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.08 EPS. As a group, sell-side analysts expect that National Health Investors will post 4.42 earnings per share for the current year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.33%. National Health Investors’s payout ratio is presently 123.71%.

Institutional Investors Weigh In On National Health Investors

Several institutional investors have recently bought and sold shares of NHI. Geode Capital Management LLC raised its stake in shares of National Health Investors by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,094,570 shares of the real estate investment trust’s stock worth $92,026,000 after purchasing an additional 8,540 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in National Health Investors by 17.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock worth $71,651,000 after acquiring an additional 123,596 shares during the last quarter. Land & Buildings Investment Management LLC boosted its holdings in shares of National Health Investors by 4.6% during the second quarter. Land & Buildings Investment Management LLC now owns 417,834 shares of the real estate investment trust’s stock worth $28,300,000 after acquiring an additional 18,232 shares during the period. Zimmer Partners LP acquired a new position in shares of National Health Investors in the third quarter valued at approximately $25,218,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of National Health Investors by 332.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust’s stock worth $20,370,000 after purchasing an additional 186,238 shares during the period. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.